+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rat Model Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 117 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5685041
The purpose of this research study titled Rat Model Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030 is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global rat model market. This report presents and analyzes the major trends prevalent in the global rat model market and the market size and forecast.

This report categorizes the global rat model market in terms of rat type, technologies, applications, usage areas, and geographical distribution. Based on rat types, the global rat model market is categorized into outbred, conditioned, knockout, and other rat types. Nuclear transferase, microinjection, embryonic stem cell, and others are the technologies considered for the purpose of this study. Based on applications, the global rat model market is studied for toxicology, CNS, oncology, immunology and inflammation, diabetes, and others. Whereas, rat models find usage in CROs, research and academia, and healthcare companies. Market size and forecast for each mentioned segment for the period 2020-2030 is presented in the report along with respective CAGRs for the forecast duration 2022-2030.

The market size and forecast of each considered geographical market are presented for the period 2020-2030 along with CAGRs for the forecast period 2022-2030 in this study and are further cross-sectional presented in terms of rat type, technology, application, usage area, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global rat model market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent positions in the rat model market. The key players profiled in this report are Biomere Biomedical Research Models, Inc., Charles River Laboratories, Covance, Inc., genOway S.A., Harlan Laboratories, Inc. (Envigo), Horizon Discovery Group Plc., Janvier Labs, SAGE Labs, Taconic Biosciences, Inc., Transposagen Biopharmaceuticals, Inc. and Transviragen Inc.

The global rat model market is studied for the following types:

  • Outbred
  • Conditioned
  • Knockout
  • Others
Several rat models including genetically conditioned or modified rats are commercially available for pharmaceutical and biotech research. In 2016, outbred rat type segment dominated the global rat model market due to the availability of genetic variants evident in the last four generations. Use of such rat models allow specific and enhanced research and also predict reaction variation for the same drug by separate animals. Outbred rat models are majorly not developed in-house and hence dependence on commercial breeding suppliers is observed. On the other hand, the demand for other variants such as knockout rat models is on the rise. Their demand in research areas for neurodegenerative diseases, oncology, cardiovascular, and other chronic diseases is observed to be growing.

The global rat model market is studied for the following technologies:

  • Nuclear Transferase
  • Microinjection
  • Embryonic Stem Cell
  • Other Technology
Among the considered technologies embryonic stem cells take the largest revenue share of the global rat model market. Technologies such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are also currently experiencing huge demand. Growing need for genetically modified and conditioned models, the usage of CRISPR technology is experiencing growth in the application, particularly in rat model-based research. Other technologies such as biolistic, Zinc Finger Nuclease (ZFN), and vector-mediated gene transfer are also anticipated to undergo faster yet steady demand through the forecast period.

Geographically, the global rat model market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America currently dominates the global rat model market. Proliferation of pharmaceutical, drug discovery and development and biotechnology industries in the region, and ever-growing scope of biotechnology research activities are the key factors contributing to the dominance of North America rat model market. Growing funding in research and development activities in North America, touting the need for new drug discoveries has further led to the dominance of the region. Additionally, Asia Pacific is anticipated to be the fastest-progressing regional market for rat model. Significant growth of biotechnology research industry in the region along with growth in CRO activities Asia Pacific has led to the fastest market growth. Furthermore, Europe market is chiefly experience growth on the basis of prompt adoption of latest biotechnology and pharma technologies.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Rat Model market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Rat Model market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Rat

  • Outbred
  • Conditioned
  • Knockout
  • Others

Technology

  • Nuclear Transferase
  • Microinjection
  • Embryonic Stem Cell
  • Other Technology

Application

  • Toxicology
  • CNS
  • Oncology
  • Immunology and inflammation
  • Diabetes
  • Others

End-users

  • CROs
  • Research and Academia
  • Healthcare Companies

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Rat Model market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Rat Model market?
  • Which is the largest regional market for Rat Model market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Rat Model market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Rat Model market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Rat Model Market
2.2. Global Rat Model Market, By Rat, 2021 (US$ Million)
2.3. Global Rat Model Market, By Technology, 2021 (US$ Million)
2.4. Global Rat Model Market, By Application, 2021 (US$ Million)
2.5. Global Rat Model Market, By End-users, 2021 (US$ Million)
2.6. Global Rat Model Market, By Geography, 2021 (US$ Million)
2.7. Impact of Covid 19
2.8. Attractive Investment Proposition by Geography, 2021
2.9. Competitive Analysis
2.9.1. Market Positioning of Key Rat Model Market Vendors
2.9.2. Strategies Adopted by Rat Model Market Vendors
2.9.3. Key Industry Strategies
3. Rat Model Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Rat Model Market Value, 2020-2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
4. Rat Model Market: By Rat, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Outbred
4.3.2. Conditioned
4.3.3. Knockout
4.3.4. Others
5. Rat Model Market: By Technology, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Nuclear Transferase
5.3.2. Microinjection
5.3.3. Embryonic Stem Cell
5.3.4. Other Technology
6. Rat Model Market: By Application, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Toxicology
6.3.2. CNS
6.3.3. Oncology
6.3.4. Immunology and inflammation
6.3.5. Diabetes
6.3.6. Others
7. Rat Model Market: By End-users, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2021 Versus 2030
7.3. Market Segmentation
7.3.1. CROs
7.3.2. Research and Academia
7.3.3. Healthcare Companies
8. North America Rat Model Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Rat Model Market: By Rat, 2020-2030, USD (Million)
8.3. Rat Model Market: By Technology, 2020-2030, USD (Million)
8.4. Rat Model Market: By Application, 2020-2030, USD (Million)
8.5. Rat Model Market: By End-users, 2020-2030, USD (Million)
8.6.Rat Model Market: By Region, 2020-2030, USD (Million)
8.6.1.North America
8.6.1.1. U.S.
8.6.1.2. Canada
8.6.1.3. Rest of North America
9. UK and European Union Rat Model Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Rat Model Market: By Rat, 2020-2030, USD (Million)
9.3. Rat Model Market: By Technology, 2020-2030, USD (Million)
9.4. Rat Model Market: By Application, 2020-2030, USD (Million)
9.5. Rat Model Market: By End-users, 2020-2030, USD (Million)
9.6.Rat Model Market: By Region, 2020-2030, USD (Million)
9.6.1.UK and European Union
9.6.1.1. UK
9.6.1.2. Germany
9.6.1.3. Spain
9.6.1.4. Italy
9.6.1.5. France
9.6.1.6. Rest of Europe
10. Asia Pacific Rat Model Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Rat Model Market: By Rat, 2020-2030, USD (Million)
10.3. Rat Model Market: By Technology, 2020-2030, USD (Million)
10.4. Rat Model Market: By Application, 2020-2030, USD (Million)
10.5. Rat Model Market: By End-users, 2020-2030, USD (Million)
10.6.Rat Model Market: By Region, 2020-2030, USD (Million)
10.6.1.Asia Pacific
10.6.1.1. China
10.6.1.2. Japan
10.6.1.3. India
10.6.1.4. Australia
10.6.1.5. South Korea
10.6.1.6. Rest of Asia Pacific
11. Latin America Rat Model Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Rat Model Market: By Rat, 2020-2030, USD (Million)
11.3. Rat Model Market: By Technology, 2020-2030, USD (Million)
11.4. Rat Model Market: By Application, 2020-2030, USD (Million)
11.5. Rat Model Market: By End-users, 2020-2030, USD (Million)
11.6.Rat Model Market: By Region, 2020-2030, USD (Million)
11.6.1.Latin America
11.6.1.1. Brazil
11.6.1.2. Mexico
11.6.1.3. Rest of Latin America
12. Middle East and Africa Rat Model Market, 2020-2030, USD (Million)
12.1. Market Overview
12.2. Rat Model Market: By Rat, 2020-2030, USD (Million)
12.3. Rat Model Market: By Technology, 2020-2030, USD (Million)
12.4. Rat Model Market: By Application, 2020-2030, USD (Million)
12.5. Rat Model Market: By End-users, 2020-2030, USD (Million)
12.6.Rat Model Market: By Region, 2020-2030, USD (Million)
12.6.1.Middle East and Africa
12.6.1.1. GCC
12.6.1.2. Africa
12.6.1.3. Rest of Middle East and Africa
13. Company Profile
13.1. Biomere Biomedical Research Models, Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Charles River Laboratories
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Covance, Inc.
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. genOway S.A.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Harlan Laboratories, Inc. (Envigo)
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Horizon Discovery Group Plc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Janvier Labs
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. SAGE Labs
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Taconic Biosciences, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Transposagen Biopharmaceuticals, Inc.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Transviragen Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Other Notable Players
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
List of Figures
Figure 1 Global Rat Model Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Rat Model Market: Quality Assurance
Figure 5 Global Rat Model Market, By Rat, 2021
Figure 6 Global Rat Model Market, By Technology, 2021
Figure 7 Global Rat Model Market, By Application, 2021
Figure 8 Global Rat Model Market, By End-users, 2021
Figure 9 Global Rat Model Market, By Geography, 2021
Figure 10 Global Rat Model Market, By Rat, 2021 Vs 2030, %
Figure 11 Global Rat Model Market, By Technology, 2021 Vs 2030, %
Figure 12 Global Rat Model Market, By Application, 2021 Vs 2030, %
Figure 13 Global Rat Model Market, By End-users, 2021 Vs 2030, %
Figure 14 U.S. Rat Model Market (US$ Million), 2020 - 2030
Figure 15 Canada Rat Model Market (US$ Million), 2020 - 2030
Figure 16 Rest of North America Rat Model Market (US$ Million), 2020 - 2030
Figure 17 UK Rat Model Market (US$ Million), 2020 - 2030
Figure 18 Germany Rat Model Market (US$ Million), 2020 - 2030
Figure 19 Spain Rat Model Market (US$ Million), 2020 - 2030
Figure 20 Italy Rat Model Market (US$ Million), 2020 - 2030
Figure 21 France Rat Model Market (US$ Million), 2020 - 2030
Figure 22 Rest of Europe Rat Model Market (US$ Million), 2020 - 2030
Figure 23 China Rat Model Market (US$ Million), 2020 - 2030
Figure 24 Japan Rat Model Market (US$ Million), 2020 - 2030
Figure 25 India Rat Model Market (US$ Million), 2020 - 2030
Figure 26 Australia Rat Model Market (US$ Million), 2020 - 2030
Figure 27 South Korea Rat Model Market (US$ Million), 2020 - 2030
Figure 28 Rest of Asia Rat Model Market (US$ Million), 2020 - 2030
Figure 29 Brazil Rat Model Market (US$ Million), 2020 - 2030
Figure 30 Mexico Rat Model Market (US$ Million), 2020 - 2030
Figure 31 Rest of Latin America Rat Model Market (US$ Million), 2020 - 2030
Figure 32 GCC Rat Model Market (US$ Million), 2020 - 2030
Figure 33 Africa Rat Model Market (US$ Million), 2020 - 2030
Figure 34 Rest of Middle East and Africa Rat Model Market (US$ Million), 2020 - 2030

Companies Mentioned

  • Biomere Biomedical Research Models Inc.
  • Charles River Laboratories
  • Covance Inc.
  • genOway S.A.
  • Harlan Laboratories Inc. (Envigo)
  • Horizon Discovery Group Plc.
  • Janvier Labs
  • SAGE Labs
  • Taconic Biosciences Inc.
  • Transposagen Biopharmaceuticals